IPP Bureau
NMPA approval for first BCMA CAR-T Therapy paves way for more multiple myeloma cell therapies, says GlobalData
By IPP Bureau - July 11, 2023
Approval to dramatically change CAR-T therapies landscape
Sumitomo Pharma America launches as new combined organization
By IPP Bureau - July 11, 2023
SMPA's diverse portfolio includes six marketed products and a robust pipeline of early- to late-stage assets
Novavax's Nuvaxovid receives full marketing authorization in the EU
By IPP Bureau - July 10, 2023
Marketing Authorization replaces conditional Marketing Authorization and is first for Novavax in the EU
Biotech startups are crucial to India’s future economy, says Dr Jitendra Singh
By IPP Bureau - July 10, 2023
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
Moderna announces regulatory submissions for its RSV vaccine
By IPP Bureau - July 10, 2023
The company has submitted marketing authorization applications for mRNA-1345 with the European Medicines Agency (EMA), Swissmedic in Switzerland, and the Therapeutic Goods Administration (TGA) in Australia
Thermo Fisher Scientific to acquire CorEvitas for $912.5 million
By IPP Bureau - July 10, 2023
Advances clinical research capabilities with leading regulatory grade registries platform
Astellas receives FDA priority review for Zolbetuximab biologics license application
By IPP Bureau - July 10, 2023
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
.jpg "L V Prasad Eye Institute and Indian Oil sign MoU to provide care to children with eye cancer")
L V Prasad Eye Institute and Indian Oil sign MoU to provide care to children with eye cancer
By IPP Bureau - July 08, 2023
The collaboration aims to raise awareness about eye cancer, provide medical and surgical treatment support to children and supply nutritional supplements to aid in their faster recovery.
Sirolimus drug coated balloons is an alternative to stents, say Cardiologists
By IPP Bureau - July 08, 2023
Especially valuable for young patients with multiple blocks & underlying conditions that may render angioplasty procedures with drug-eluting stents ineffective
HMD Foundation donates iLAB unit to Amrita Hospital Faridabad
By IPP Bureau - July 08, 2023
With close to 30-40 basic screening tests available, the unit encompasses all the essential parameters typically covered in annual health check-ups
Cytel acquires French group stève consultants to expand real-world analytics capabilities
By IPP Bureau - July 08, 2023
Cytel excels at using proven quantitative techniques to transform real-world data into actionable insights
Ashland collaborates with University of Mississippi School of Pharmacy to sponsor advanced pharmaceutical tableting course
By IPP Bureau - July 08, 2023
This four-day course is designed for professionals in the pharmaceutical, nutraceutical, and related industries
Dabur India expects 10%+ consolidated growth in Q1 FY24
By IPP Bureau - July 07, 2023
However, PAT growth will be lower than operating profit growth mainly due to brand amortization expenditure on account of acquisition.
Aarti Drugs bags Pharmexcil Outstanding Exports Awards 2021-22
By IPP Bureau - July 07, 2023
The company has received Export Performance Award - API & Intermediaries Gold Star for the year 2021-22
Aster DM Healthcare increases stake in Malabar Institute of Medical Sciences
By IPP Bureau - July 07, 2023
Shareholding of the company in MIMS has increased from 76.01 per cent to 78.37 per cent
